Metastasis-associated in colon cancer-1 (MACC1),a newly discovered gene which controls tumor growth and metastasis,abnormally expresses in a variety of malignant tumors.As a key regulator of HGF-MET signal pathway,its coding protein can obviously promote invasion and metastasis of tumor cells.

Objective: To evaluate the application of ureteroscope-assisited laparoscopic varicocelectomy with two trocars only. Methods: We retrospectively analyzed the clinical efficacy and safety of ureteroscope-assisited laparoscopic varicocelectomy with only two trocars in management of 11 patients with grade II-III varicocele, who were treated in our hospital between Jun. 2008 to Jun. 2009 and were followed up for 3-15 months. Results: The operation was successful in all the 11 cases. The mean operation time was (19.4 ± 1.1) min (ranging 16-28 min). There were no complications after the procedure; the patients were allowed for ambulation on the next day after operation and were discharged on the third day. The sperm count was (2609 ± 208) × 104/ml three months after operation, which was significantly higher than that before operation (1463 ± 128) × 104/ml (P < 0.01). There was no recurrence or testis atrophy. Conclusion: Ureteroscope-assisited laparoscopic varicocelectomy with only two trocars is safe, effective, and easy-to-perform, and it has less complications and trauma.

Objective: To assess the value of central venous catheter in treatment of refractory urinary retention in children. Methods: Seven boys with acute urinary retention, who underwent failed routine drainage from Aug. 2007 to Jun. 2008, received paracentric suprapubic cystostomy via disposable central venous catheter. The patients were followed up for 2-11 months and the outcomes and complications were observed. Results: The catheterization processes were successful at the first try, with the mean operation time being (3.2 ± 0.4) min, ranging 2-5 min. The drainage outcomes were satisfactory and there were no complications. Conclusion: Suprapubic puncture and drainage with central venous catheter is safe and effective for children with urinary retention and is worth popularizing.

Objective To access the feasibility of ueing "flexible Uitrasonic cystoscopy (FUCS)" (Uitrasonic bronchoscope Olympus BF-UC260F-OL8 as a subslitute) for staging of bladder cancet Methods From Jun 2010 to Nov. 2010,36 patierrts with piiimary bladder urotheiial carcinoma were examined by "FUCS" before operation and were rttaged by "FUCS" findings. All patients rectived IVP and enhanced pdvc CT Non-muscle-invasive bladder cancer patierrts rem-ved TURBT, and the tumor base was routinely bopied for pathology Pathological results, traditional imaging eraliiaiton, and "FUCS" evaluation were compared. Visual analog scores (VAS) were also compared between patierrts reccing "FUCS" and rcmime cystoscopy. Results Compared with conventional cyrtoscopy, the VAS of patients receiving intraoperative "FUCS" was significantly tower (1 3 ± 0. 5 vs 4. 3 ± 0. 9, P<0. 01). Of the 36 patierrts, 28 were diagrosed as non-muscle-invasive bladder cancer (Ta + T1) and 8 were diagrosed as muscle-invasive bladder career (T2 + T3). Based on the postoperative pathologic results, "FUCS" had a 100% accuracy in diagnoeing norem Uselelinvaeive and muscle-invasive bladder cancer. Conclution "FUCS" is painless and feasible in clinical practice; it can display the depth of bladder wall invaded by tumor, and can be used for preoperative staging of primary bladder tumor.

Case-Control Studies ; Child, Preschool ; Congenital Hypothyroidism ; DNA ; genetics ; Female ; Humans ; Hypothyroidism ; genetics ; Infant ; Iodine ; metabolism ; Male ; Mutation ; Polymerase Chain Reaction ; Sodium ; metabolism ; Symporters ; genetics

One of the important approaches for further prolonging remission duration and eradicating minimal residual disease in acute leukemia is immunotherapy. Four kinds of immunotherapy for acute leukemia are under investigation: (1) monoclonal antibodies, among them, Mylotarg (cytotoxic antibiotic calicheamicin linked to CD33 Mab) is given for the treatment of refractory or relapsed acute myeloid leukemia and molecular relapse in acute promyelocytic leukemia with good results, Campath-1H (antiCD52 Mab) is administered in the treatment of prolymphocytic leukemia and Rituximab (anti-CD20 Mab) in B-PLL with high complete remission rates. Other Mabs under preclinical and clinical trials include anti-IL-2 receptor Mab for the treatment of acute T lymphocytic leukemia, anti-220 kD Mab-6G7 for acute leukemias, recombinant immune toxin BL22 (anti-CD22) for hairy cell leukemia and Mabs labeled with radio-isotopes for different types of acute leukemias; (2) adoptive cellular immunotherapy using cytokine-induced killer cell, alloreactive NK cells, allogeneic or autologous leukemic-specific CD8(+) cytotoxic T lymphocytes, and other immune effector cells; (3) cytokines and other immune modulators comprising IL-2, IL-12, GM-CSF, CD40L, FLT-3L and thalidomide and its derivatives; (4) leukemia vaccines of several different formulations including antigen-specific, leukemia cell-based, leukemia antigen-pulsed dendritic cell (DC) and leukemia-derived DC vaccines, the latter two formulations are more attractive. In conclusion, up to now, the most effective example of immunotherapy in acute leukemia is provided by the administration of Mabs, and the majority of other approaches in immunotherapy for acute leukemia although promising, need further studies.
Acute Disease ; Adoptive Transfer ; methods ; Antibodies, Monoclonal ; immunology ; therapeutic use ; Cancer Vaccines ; therapeutic use ; Humans ; Immunotherapy ; methods ; trends ; Leukemia ; immunology ; therapy

Animals ; Antioxidants ; pharmacology ; Ascorbic Acid ; pharmacology ; Cumulative Trauma Disorders ; metabolism ; Lipid Peroxidation ; drug effects ; Male ; Muscle, Skeletal ; injuries ; pathology ; Oxidation-Reduction ; Oxidative Stress ; drug effects ; Rats

Purpose:To evaluate the feasibility of irradiat ion to the metastatic retroperitoneal lymph nodes using three-dimensional confo rmal radiotherapy (3-DCRT) and to assess the irradiation side effects. Methods:From Jun. 1997 to Sep. 2000, 52 patients of metastatic retroperitoneal lymph nodes were treated with 3-DCRT.These patients had receive d radical therapy for their primary tumors. 50 of them had been proved by pathol ogical examination. Radiotherapy was designed by Elekta company’s 3-D treatmen t plan. Dose volume histography (DVH) was used to verify and optimize the radiat ion plan. Using 5～6 conformal portals,the total irradiation dose was 40 Gy an d delivered at 4～5Gy per fraction every other day,to a total of 8～10 fractions in 16～20 days. The immediate responses and side effects were evaluated accordi ng to the WHO and RTOG criterion system. Results:According to Karnofsky criterion system the median scor e was raised 21.3. Three months after irradiation, the complete ,partial and tot al response rates were 38.6%(27/70), 54.3%(38/70)and 92.9%(65/70),respect ively. The early response was related to the target volume and pathological clas sification. The smaller the target volume, the better the response(? 2 = 1 5.211,P=0.004).The anaplastic carcinoma cases had better results than the squamous carcinomas and adenocarcinomas(? 2 =13.455,P=0.009).The 1- ,2- and 3- year survival rates were 59.6%(31/52)、23.1%(12/52)and 9.6%(5/ 52),respectively. Conclusions:Three dimensional conformal radiotherapy can be con sidered as an effective and feasible approach for the treatment of metastatic r etroperitoneal lymph nodes,and no serious complications were observed.

No abstract available.

Animals ; Electrical Synapses ; Male ; Membrane Potentials ; physiology ; Neurons ; physiology ; Parietal Lobe ; cytology ; Patch-Clamp Techniques ; Rats ; Rats, Wistar